Anjar Salim
- Adventure & Outdoor Exploration
- March 27, 2026
- 11 views
The Synergy of GLP-1 Medications and Physical Activity: New Research Redefines the Future of Weight Management and Metabolic Health
The rapid ascent of glucagon-like peptide-1 (GLP-1) receptor agonists has fundamentally altered the landscape of metabolic medicine, sparking a global conversation about the necessity of traditional lifestyle interventions in an…
Budi Mulyono
- Business Travel & MICE
- March 25, 2026
- 16 views
Navigating the Logistics of GLP-1 Medications in Air Travel: Why Airlines Refuse Onboard Refrigeration and How Passengers Can Prepare
The global surge in the administration of glucagon-like peptide-1 (GLP-1) receptor agonists, such as semaglutide and tirzepatide—commercially known as Wegovy, Ozempic, Mounjaro, and Zepbound—has introduced a complex logistical challenge to…








